Chemclin Diagnostics Co., Ltd. (688468.SS)
CNY 6.97
(1.6%)
CNY 6.97
(1.6%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 110.6 Million CNY | -1.74% |
| 2022 | 112.56 Million CNY | -8.01% |
| 2021 | 122.36 Million CNY | 24.01% |
| 2020 | 98.67 Million CNY | 17.34% |
| 2019 | 84.09 Million CNY | 20.8% |
| 2018 | 69.61 Million CNY | 7.84% |
| 2017 | 64.55 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 111.09 Million CNY | 0.07% |
| 2024 Q2 | 111.01 Million CNY | -0.67% |
| 2024 Q1 | 111.76 Million CNY | 1.05% |
| 2023 FY | 110.6 Million CNY | -1.74% |
| 2023 Q2 | 112.9 Million CNY | -0.42% |
| 2023 Q1 | 113.37 Million CNY | 0.73% |
| 2023 Q4 | 110.6 Million CNY | -0.73% |
| 2023 Q3 | 111.41 Million CNY | -1.32% |
| 2022 Q3 | 121.24 Million CNY | 1.19% |
| 2022 Q2 | 119.82 Million CNY | 2.78% |
| 2022 Q1 | 116.58 Million CNY | -4.72% |
| 2022 FY | 112.56 Million CNY | -8.01% |
| 2022 Q4 | 112.56 Million CNY | -7.17% |
| 2021 FY | 122.36 Million CNY | 24.01% |
| 2021 Q1 | 107.31 Million CNY | 8.76% |
| 2021 Q4 | 122.36 Million CNY | 0.64% |
| 2021 Q3 | 121.58 Million CNY | 3.74% |
| 2021 Q2 | 117.2 Million CNY | 9.22% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q3 | - CNY | -100.0% |
| 2020 Q2 | 93.28 Million CNY | 0.0% |
| 2020 Q4 | 98.67 Million CNY | 0.0% |
| 2020 FY | 98.67 Million CNY | 17.34% |
| 2019 FY | 84.09 Million CNY | 20.8% |
| 2019 Q4 | 84.09 Million CNY | 0.0% |
| 2018 FY | 69.61 Million CNY | 7.84% |
| 2017 FY | 64.55 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 1.37 Billion CNY | 91.967% |
| Joinn Laboratories(China)Co.,Ltd. | 1.86 Billion CNY | 94.063% |
| WuXi AppTec Co., Ltd. | 4.73 Billion CNY | 97.665% |
| Autobio Diagnostics Co., Ltd. | 778.28 Million CNY | 85.789% |
| Thalys Medical Technology Group Inc. | 341.6 Million CNY | 67.622% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 248.2 Million CNY | 55.438% |